Ceftriaxone induced immune hemolytic anemia: Detection of drug-dependent antibody by ex-vivo antigen in urine

Yonsei Medical Journal

Volumn 43, Issue 3, 2002, Pages 391-394

  Kim, Sinyoung ^a   Song, Kyung Soon ^a   Kim, Hyun Ok ^a   Lee, Hwan Mo ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Ceftriaxone; Drug dependent antibody; Ex vivo antigen; Immune hemolytic anemia

Indexed keywords

ANTIBODY; ANTIGEN; BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; CEFTRIAXONE; COMPLEMENT COMPONENT C3D;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CONTROLLED STUDY; COOMBS TEST; DRUG DEGRADATION; HUMAN; KOREA; MALE; URINALYSIS;

EID: 0036309477     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2002.43.3.391     Document Type: Article

References (12)

1. Antimicrobial agents
2. Once-daily administration of ceftriaxone for the treatment of selected serious bacterial infections in children
3. Pharmacokinetic profile of ceftriaxone in man
4. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome
5. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis
6. Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection
7. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia
8. Drug-induced immune hemolytic anemia
9. Severe immune-mediated hemolytic anemia secondary to treatment with cefotetan
10. Fatal immune hemolytic anemia due to cefotetan
11. Fatal hemolysis caused by ceftriaxone
12. Fatal immune haemolysis due to a degradation product of ceftriaxone